108 related articles for article (PubMed ID: 10415794)
41. T cell gelatinases mediate basement membrane transmigration in vitro.
Leppert D; Waubant E; Galardy R; Bunnett NW; Hauser SL
J Immunol; 1995 May; 154(9):4379-89. PubMed ID: 7722295
[TBL] [Abstract][Full Text] [Related]
42. Callysponginol sulfate A, an MT1-MMP inhibitor isolated from the marine sponge Callyspongia truncata.
Fujita M; Nakao Y; Matsunaga S; van Soest RW; Itoh Y; Seiki M; Fusetani N
J Nat Prod; 2003 Apr; 66(4):569-71. PubMed ID: 12713420
[TBL] [Abstract][Full Text] [Related]
43. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
[TBL] [Abstract][Full Text] [Related]
44. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.
Cowell S; Knäuper V; Stewart ML; D'Ortho MP; Stanton H; Hembry RM; López-Otín C; Reynolds JJ; Murphy G
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic options in small abdominal aneurysms: the role of in vitro studies.
Thompson MM; Boyle JR; Crowther M; Goodall S; Wills A; Loftus IM; Bell PR
Ann N Y Acad Sci; 1999 Jun; 878():724-7. PubMed ID: 10415819
[No Abstract] [Full Text] [Related]
46. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
Lampert K; Machein U; Machein MR; Conca W; Peter HH; Volk B
Am J Pathol; 1998 Aug; 153(2):429-37. PubMed ID: 9708803
[TBL] [Abstract][Full Text] [Related]
47. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
48. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
Ochieng J; Fridman R; Nangia-Makker P; Kleiner DE; Liotta LA; Stetler-Stevenson WG; Raz A
Biochemistry; 1994 Nov; 33(47):14109-14. PubMed ID: 7947821
[TBL] [Abstract][Full Text] [Related]
49. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
[TBL] [Abstract][Full Text] [Related]
50. Chemokine-induced extravasation of MonoMac 6 cells: chemotaxis and MMP activity.
Klier CM; Nelson PJ
Ann N Y Acad Sci; 1999 Jun; 878():575-7. PubMed ID: 10415777
[No Abstract] [Full Text] [Related]
51. Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.
Moriyama H; Tsukida T; Inoue Y; Kondo H; Yoshino K; Nishimura S
Bioorg Med Chem Lett; 2003 Aug; 13(16):2737-40. PubMed ID: 12873504
[TBL] [Abstract][Full Text] [Related]
52. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
[TBL] [Abstract][Full Text] [Related]
53. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.
Tamura Y; Watanabe F; Nakatani T; Yasui K; Fuji M; Komurasaki T; Tsuzuki H; Maekawa R; Yoshioka T; Kawada K; Sugita K; Ohtani M
J Med Chem; 1998 Feb; 41(4):640-9. PubMed ID: 9484512
[TBL] [Abstract][Full Text] [Related]
54. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.
Grenier D; Plamondon P; Sorsa T; Lee HM; McNamara T; Ramamurthy NS; Golub LM; Teronen O; Mayrand D
J Periodontol; 2002 Jan; 73(1):79-85. PubMed ID: 11846203
[TBL] [Abstract][Full Text] [Related]
56. Gelatinase A and APP.
Miyazaki K; Funahashi K; Umeda M; Nakano A
Nature; 1994 Apr; 368(6473):695-6. PubMed ID: 8179718
[No Abstract] [Full Text] [Related]
57. Balance in asthma between matrix metalloproteinases and their inhibitors.
Mautino G; Capony F; Bousquet J; Vignola AM
J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):530-3. PubMed ID: 10482823
[No Abstract] [Full Text] [Related]
58. Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.
Vassiliou S; Mucha A; Cuniasse P; Georgiadis D; Lucet-Levannier K; Beau F; Kannan R; Murphy G; Knäuper V; Rio MC; Basset P; Yiotakis A; Dive V
J Med Chem; 1999 Jul; 42(14):2610-20. PubMed ID: 10411481
[TBL] [Abstract][Full Text] [Related]
59. Coordinate expression of matrix-degrading proteinases and their activators and inhibitors in bovine skeletal muscle.
Balcerzak D; Querengesser L; Dixon WT; Baracos VE
J Anim Sci; 2001 Jan; 79(1):94-107. PubMed ID: 11204721
[TBL] [Abstract][Full Text] [Related]
60. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
